Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England
A meningococcal group B vaccine was introduced in the United Kingdom as part of the infant vaccination program. Investigators from Public Health England assessed the effect of this vaccination on the incidence of meningococcal group B disease.
Gespeichert in:
| Veröffentlicht in: | The New England journal of medicine 2020-01, Vol.382 (4), p.309-317 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 317 |
|---|---|
| container_issue | 4 |
| container_start_page | 309 |
| container_title | The New England journal of medicine |
| container_volume | 382 |
| creator | Ladhani, Shamez N Andrews, Nick Parikh, Sydel R Campbell, Helen White, Joanne Edelstein, Michael Bai, Xilian Lucidarme, Jay Borrow, Ray Ramsay, Mary E |
| description | A meningococcal group B vaccine was introduced in the United Kingdom as part of the infant vaccination program. Investigators from Public Health England assessed the effect of this vaccination on the incidence of meningococcal group B disease. |
| doi_str_mv | 10.1056/NEJMoa1901229 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2344228984</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2344228984</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-507a3d3120bcc036377f78cc661d234e526d0efd0e85a85dcdd3b5de445a74d53</originalsourceid><addsrcrecordid>eNp10M1LwzAYBvAgis7p0asERJiHatJ89ujGnJNNL-q1ZEk6O9ZkNi3if29Gp6DgC-G9_PLw8gBwhtE1RozfPI4f5l7hDOE0zfZADzNCEkoR3wc9hFKZUJGRI3AcwgrFwTQ7BEcEZwJzwXtg_qq0Lp1qSu-gL-DUFco1AX6UzRucW1e6pddea7WGk9q3GziE3Q8LB3QUwfAKlg6O3XKtnDkBB4VaB3u6233wcjd-Ht0ns6fJdHQ7SzTJUJMwJBQxBKdooTUinAhRCKk159ikhFqWcoNsEZ9kSjKjjSELZiylTAlqGOmDQZe7qf17a0OTV2XQdh1vsL4NeQyhaSozSSO9-ENXvq1dvG6rCI-9SRlV0ild-xBqW-SbuqxU_ZljlG97zn_1HP35LrVdVNb86O9iI7jsQFWF3NlV9U_QFwyPgRI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2343601288</pqid></control><display><type>article</type><title>Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>ProQuest Central UK/Ireland</source><source>New England Journal of Medicine</source><creator>Ladhani, Shamez N ; Andrews, Nick ; Parikh, Sydel R ; Campbell, Helen ; White, Joanne ; Edelstein, Michael ; Bai, Xilian ; Lucidarme, Jay ; Borrow, Ray ; Ramsay, Mary E</creator><creatorcontrib>Ladhani, Shamez N ; Andrews, Nick ; Parikh, Sydel R ; Campbell, Helen ; White, Joanne ; Edelstein, Michael ; Bai, Xilian ; Lucidarme, Jay ; Borrow, Ray ; Ramsay, Mary E</creatorcontrib><description>A meningococcal group B vaccine was introduced in the United Kingdom as part of the infant vaccination program. Investigators from Public Health England assessed the effect of this vaccination on the incidence of meningococcal group B disease.</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMoa1901229</identifier><identifier>PMID: 31971676</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Age ; Antigens ; Child, Preschool ; Children ; Children & youth ; Childrens health ; Confidence Intervals ; England - epidemiology ; Epidemics ; Estimates ; Humans ; Immunization Programs ; Immunization Schedule ; Immunization, Secondary ; Incidence ; Infant ; Infant, Newborn ; Infants ; Information systems ; Invasive meningococcal disease ; Laboratories ; Meningococcal disease ; Meningococcal Infections - epidemiology ; Meningococcal Infections - prevention & control ; Meningococcal Vaccines - immunology ; Neisseria meningitidis, Serogroup B ; Peptides ; Proteins ; Public health ; State Medicine ; Treatment Outcome ; United Kingdom ; Vaccination ; Vaccine efficacy ; Vaccines</subject><ispartof>The New England journal of medicine, 2020-01, Vol.382 (4), p.309-317</ispartof><rights>Copyright © 2020 Massachusetts Medical Society. All rights reserved.</rights><rights>Copyright © 2020 Massachusetts Medical Society.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-507a3d3120bcc036377f78cc661d234e526d0efd0e85a85dcdd3b5de445a74d53</citedby><cites>FETCH-LOGICAL-c390t-507a3d3120bcc036377f78cc661d234e526d0efd0e85a85dcdd3b5de445a74d53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMoa1901229$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2343601288?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,2759,2760,26103,27924,27925,52382,54064,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31971676$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ladhani, Shamez N</creatorcontrib><creatorcontrib>Andrews, Nick</creatorcontrib><creatorcontrib>Parikh, Sydel R</creatorcontrib><creatorcontrib>Campbell, Helen</creatorcontrib><creatorcontrib>White, Joanne</creatorcontrib><creatorcontrib>Edelstein, Michael</creatorcontrib><creatorcontrib>Bai, Xilian</creatorcontrib><creatorcontrib>Lucidarme, Jay</creatorcontrib><creatorcontrib>Borrow, Ray</creatorcontrib><creatorcontrib>Ramsay, Mary E</creatorcontrib><title>Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>A meningococcal group B vaccine was introduced in the United Kingdom as part of the infant vaccination program. Investigators from Public Health England assessed the effect of this vaccination on the incidence of meningococcal group B disease.</description><subject>Age</subject><subject>Antigens</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>Children & youth</subject><subject>Childrens health</subject><subject>Confidence Intervals</subject><subject>England - epidemiology</subject><subject>Epidemics</subject><subject>Estimates</subject><subject>Humans</subject><subject>Immunization Programs</subject><subject>Immunization Schedule</subject><subject>Immunization, Secondary</subject><subject>Incidence</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infants</subject><subject>Information systems</subject><subject>Invasive meningococcal disease</subject><subject>Laboratories</subject><subject>Meningococcal disease</subject><subject>Meningococcal Infections - epidemiology</subject><subject>Meningococcal Infections - prevention & control</subject><subject>Meningococcal Vaccines - immunology</subject><subject>Neisseria meningitidis, Serogroup B</subject><subject>Peptides</subject><subject>Proteins</subject><subject>Public health</subject><subject>State Medicine</subject><subject>Treatment Outcome</subject><subject>United Kingdom</subject><subject>Vaccination</subject><subject>Vaccine efficacy</subject><subject>Vaccines</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp10M1LwzAYBvAgis7p0asERJiHatJ89ujGnJNNL-q1ZEk6O9ZkNi3if29Gp6DgC-G9_PLw8gBwhtE1RozfPI4f5l7hDOE0zfZADzNCEkoR3wc9hFKZUJGRI3AcwgrFwTQ7BEcEZwJzwXtg_qq0Lp1qSu-gL-DUFco1AX6UzRucW1e6pddea7WGk9q3GziE3Q8LB3QUwfAKlg6O3XKtnDkBB4VaB3u6233wcjd-Ht0ns6fJdHQ7SzTJUJMwJBQxBKdooTUinAhRCKk159ikhFqWcoNsEZ9kSjKjjSELZiylTAlqGOmDQZe7qf17a0OTV2XQdh1vsL4NeQyhaSozSSO9-ENXvq1dvG6rCI-9SRlV0ild-xBqW-SbuqxU_ZljlG97zn_1HP35LrVdVNb86O9iI7jsQFWF3NlV9U_QFwyPgRI</recordid><startdate>20200123</startdate><enddate>20200123</enddate><creator>Ladhani, Shamez N</creator><creator>Andrews, Nick</creator><creator>Parikh, Sydel R</creator><creator>Campbell, Helen</creator><creator>White, Joanne</creator><creator>Edelstein, Michael</creator><creator>Bai, Xilian</creator><creator>Lucidarme, Jay</creator><creator>Borrow, Ray</creator><creator>Ramsay, Mary E</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20200123</creationdate><title>Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England</title><author>Ladhani, Shamez N ; Andrews, Nick ; Parikh, Sydel R ; Campbell, Helen ; White, Joanne ; Edelstein, Michael ; Bai, Xilian ; Lucidarme, Jay ; Borrow, Ray ; Ramsay, Mary E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-507a3d3120bcc036377f78cc661d234e526d0efd0e85a85dcdd3b5de445a74d53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Age</topic><topic>Antigens</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>Children & youth</topic><topic>Childrens health</topic><topic>Confidence Intervals</topic><topic>England - epidemiology</topic><topic>Epidemics</topic><topic>Estimates</topic><topic>Humans</topic><topic>Immunization Programs</topic><topic>Immunization Schedule</topic><topic>Immunization, Secondary</topic><topic>Incidence</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infants</topic><topic>Information systems</topic><topic>Invasive meningococcal disease</topic><topic>Laboratories</topic><topic>Meningococcal disease</topic><topic>Meningococcal Infections - epidemiology</topic><topic>Meningococcal Infections - prevention & control</topic><topic>Meningococcal Vaccines - immunology</topic><topic>Neisseria meningitidis, Serogroup B</topic><topic>Peptides</topic><topic>Proteins</topic><topic>Public health</topic><topic>State Medicine</topic><topic>Treatment Outcome</topic><topic>United Kingdom</topic><topic>Vaccination</topic><topic>Vaccine efficacy</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ladhani, Shamez N</creatorcontrib><creatorcontrib>Andrews, Nick</creatorcontrib><creatorcontrib>Parikh, Sydel R</creatorcontrib><creatorcontrib>Campbell, Helen</creatorcontrib><creatorcontrib>White, Joanne</creatorcontrib><creatorcontrib>Edelstein, Michael</creatorcontrib><creatorcontrib>Bai, Xilian</creatorcontrib><creatorcontrib>Lucidarme, Jay</creatorcontrib><creatorcontrib>Borrow, Ray</creatorcontrib><creatorcontrib>Ramsay, Mary E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ladhani, Shamez N</au><au>Andrews, Nick</au><au>Parikh, Sydel R</au><au>Campbell, Helen</au><au>White, Joanne</au><au>Edelstein, Michael</au><au>Bai, Xilian</au><au>Lucidarme, Jay</au><au>Borrow, Ray</au><au>Ramsay, Mary E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2020-01-23</date><risdate>2020</risdate><volume>382</volume><issue>4</issue><spage>309</spage><epage>317</epage><pages>309-317</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>A meningococcal group B vaccine was introduced in the United Kingdom as part of the infant vaccination program. Investigators from Public Health England assessed the effect of this vaccination on the incidence of meningococcal group B disease.</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>31971676</pmid><doi>10.1056/NEJMoa1901229</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0028-4793 |
| ispartof | The New England journal of medicine, 2020-01, Vol.382 (4), p.309-317 |
| issn | 0028-4793 1533-4406 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2344228984 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals; ProQuest Central UK/Ireland; New England Journal of Medicine |
| subjects | Age Antigens Child, Preschool Children Children & youth Childrens health Confidence Intervals England - epidemiology Epidemics Estimates Humans Immunization Programs Immunization Schedule Immunization, Secondary Incidence Infant Infant, Newborn Infants Information systems Invasive meningococcal disease Laboratories Meningococcal disease Meningococcal Infections - epidemiology Meningococcal Infections - prevention & control Meningococcal Vaccines - immunology Neisseria meningitidis, Serogroup B Peptides Proteins Public health State Medicine Treatment Outcome United Kingdom Vaccination Vaccine efficacy Vaccines |
| title | Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T08%3A18%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vaccination%20of%20Infants%20with%20Meningococcal%20Group%20B%20Vaccine%20(4CMenB)%20in%20England&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Ladhani,%20Shamez%20N&rft.date=2020-01-23&rft.volume=382&rft.issue=4&rft.spage=309&rft.epage=317&rft.pages=309-317&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJMoa1901229&rft_dat=%3Cproquest_cross%3E2344228984%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2343601288&rft_id=info:pmid/31971676&rfr_iscdi=true |